As the Ripple vs. Securities and Exchange Commission (SEC) case reached its final stage, spot exchange-traded funds (ETFs) ...

LB Pharmaceuticals (LBRX) stock is on track for a Nasdaq listing as the company focused on neuropsychiatric diseases seeks a ...

The U.S. Securities and Exchange Commission named a senior military judge as enforcement director on Thursday, in what legal ...

The U.S. Court of Appeals for the Second Circuit gave a surprising verdict in the Ripple vs. Securities and Exchange ...

For Ripple, this marks a long-awaited closure. The company can disperse XRP without worrying about the SEC breathing down its ...

Here’s our weekly roundup of the most-read articles at Barron’s Advisor.

Activist investors report to the SEC on Rapid7, Resideo Technologies, Appian, Garrett Motion, Arcellx, and Disc Medicine.

CEO Christopher Gibson was one of those sellers, with a Thursday reveal that he had sold 40,390 shares of Recursion's common ...

Cracker Barrel joins Target, Bud Light and other companies facing public outcry over corporate decisions as its new logo ...

On a very good Friday for the stock market, Biohaven 's ( BHVN 6.33%) performance was exceptional. The clinical-stage biotech ...

Former state Treasurer Allison Ball claimed the JPMorgan CEO berated her, and she urged conservatives to stack pension boards ...

A wave of asset managers filed updated paperwork for spot XRP ETFs on Friday, signaling a renewed push to secure approval ...